Articles From: Insignia Systems, Inc. Added to Russell Microcap® Index to Ipsen submits marketing authorization applications in the US and Europe for Somatuline® (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)


Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today announced that it was added to the Russell Microcap® Index.
Sign-up for Insignia Systems, Inc. Added to Russell Microcap® Index investment picks
2014/7/1
BOSTON , July 1, 2014 /PRNewswire/ -- InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced that it has been selected to join the Russell Microcap Index, as of June 27 , 2014.
Sign-up for InspireMD Selected for Inclusion in the Russell Microcap® Index investment picks
Enterprise Customers, Rich Product Offerings Drive Massive Sales Growth for Managed and Cloud Solutions PORTLAND, Ore.
Sign-up for Integra Recognized as Mitel's Top Cloud Partner in North America for 2013 investment picks
2014/7/1
McAfee , part of Intel Security, today announced that leading research firm Gartner, Inc. has positioned the company in the Leaders quadrant in its “Magic Quadrant for Secure Web Gateways” as published on June 23, 2014.
Sign-up for Intel Security (McAfee), Positioned in the Leaders Quadrant for Secure Web Gateway in Gartner’s Latest Magic Quadrant investment picks
2014/7/1
Interactive Brokers Group, Inc. (NASDAQ GS: IBKR) an automated global electronic broker and market maker, today reported its Electronic Brokerage monthly performance metrics for June.
Sign-up for Interactive Brokers Group Reports Brokerage Metrics for June 2014 investment picks
Intercontinental Exchange (NYSE:ICE), the leading global network of exchanges and clearing houses, today completed the transition of Liffe U.S. futures and options contracts to the ICE futures exchanges, trading platform and clearing infrastructure.
Sign-up for Intercontinental Exchange Completes Liffe U.S. Transition to ICE; Trading and Clearing for MSCI Equity Index and Precious Metal Contracts Successfully Transitioned investment picks
2014/7/1
Combined Company, Veritiv Corporation, Trades on NYSE MEMPHIS, Tenn.
Sign-up for International Paper Announces Completion of xpedx Spinoff and Merger with Unisource investment picks
Interval International, a prominent worldwide provider of vacation services and an operating business of Interval Leisure Group (Nasdaq: IILG), announced the addition of The Bliss Jungle Riviera Maya in Mexico.
Sign-up for Interval International Adds Fourth Grupo Vidanta Property in Mexico to Its Worldwide Exchange Network investment picks
INTERXION HOLDING NV (NYSE:INXN), a leading European provider of cloud and carrier-neutral colocation data centre services, announced today that its customers can establish private connections to both Amazon Web Services and Microsoft Azure from all of its 37 data centres across 11 countries through the presence of Amazon’s Direct Connect Partners and Microsoft’s ExpressRoute Partners.
Sign-up for Interxion’s Carrier Community Enables Access to AWS Direct Connect and Microsoft Azure ExpressRoute investment picks
Trans Ova Platform Combined with Intrexon's Technologies to Advance Cattle Genetics SIOUX CENTER, Iowa and GERMANTOWN, Md.
Sign-up for Intrexon to Acquire Trans Ova Genetics investment picks
SUNNYVALE, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Intuitive Surgical (Nasdaq:ISRG) and Adachi Co.
Sign-up for Intuitive Surgical to Begin Direct Sales of da Vinci(R) Surgical Systems in Japan investment picks
2014/7/1
ATLANTA , July 1, 2014 /PRNewswire/ -- The Board of Trustees of each of the Invesco closed-end funds listed below today declared the following dividends.
Sign-up for Invesco Closed-End Funds Declare Dividends investment picks
2014/7/1
NEW YORK , July 1, 2014 /PRNewswire/ -- Invesco Private Capital recently held its sixth annual Tools for Success © Forum in San Francisco .
Sign-up for Invesco Private Capital Hosts Tools for Success© Forum investment picks
2014/7/1
ATLANTA , July 1, 2014 /PRNewswire/ -- Invesco US announced today the launch of the Invesco Conservative Income Fund, an ultra-short bond fund seeking to provide investors the potential for greater rates of return and yield than cash equivalent securities, yet with a lower risk profile than typical diversified short-term bond funds.
Sign-up for Invesco US Launches Conservative Income Fund investment picks
2014/7/1
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of MICROS Systems, Inc. (NasdaqGS:MCRS) (“MICROS”) in connection with the sale of the Company to Oracle Corporation.
Sign-up for INVESTOR ALERT – MICROS Systems, Inc.: The Law Offices of Vincent Wong Investigates the Sale of MICROS Systems, Inc.: – MCRS investment picks
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of a class (the “Class”) comprising all purchasers of the common stock of Vertex Pharmaceuticals Incorporated (“Vertex” or the “Company”) (NASDAQ:VRTX) between May 7, 2012 and May 29, 2012, inclusive (the “Class Period”). Please contact us at (646) 539-8980, or at shareholders@glancylaw.com to discuss this matter.
Sign-up for INVESTOR ALERT: Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated Announced by Glancy Binkow & Goldberg LLP investment picks
Glancy Binkow & Goldberg LLP reminds investors of Blucora, Inc. (“Blucora” or the “Company”) (NASDAQ:BCOR) that all purchasers of Blucora securities between November 5, 2013, and February 20, 2014, inclusive (the “Class Period”), have until July 14, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Blucora, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of INSYS Therapeutics, Inc. (“INSYS” or the “Company”) (NASDAQ:INSY) that all purchasers of INSYS securities between May 2, 2013 and May 8, 2014, inclusive (the “Class Period”), have until July 14, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against INSYS Therapeutics, Inc. investment picks
2014/7/1
Glancy Binkow & Goldberg LLP reminds investors of Ruby Tuesday, Inc. (“Ruby Tuesday” or the “Company”) (NYSE:RT) that all purchasers of Ruby Tuesday common stock between April 11, 2013 and October 9, 2013, inclusive (the “Class Period”), have until July 7, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Ruby Tuesday, Inc. investment picks
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Northwest Biotherapeutics, Inc. (“Northwest Biotherapeutics” or the “Company”) (NASDAQ:NWBO) concerning possible violations of federal securities laws.
Sign-up for INVESTOR ALERT: Investigation of Northwest Biotherapeutics, Inc. Announced by Glancy Binkow & Goldberg LLP investment picks
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of The Bancorp, Inc. ("Bancorp" or the "Company") (NASDAQ:TBBK) concerning possible violations of federal securities laws.
Sign-up for INVESTOR ALERT: Investigation of The Bancorp, Inc. Announced by Glancy Binkow & Goldberg LLP investment picks
SHORT HILLS, N.J. , July 1, 2014 /PRNewswire/ -- Investors Bancorp, Inc. (Nasdaq: ISBC) , announced that it expects to report earnings for the second quarter ended June 30, 2014 , on Thursday, July 24, 2014 at approximately 5:00 p.m. Eastern Time (ET). A copy of the news release will be immediately available on its website, www.myinvestorsbank.com .
Sign-up for Investors Bancorp, Inc. Announces Date for Second Quarter Earnings Conference Call investment picks
InVivo Therapeutics Holdings Corp.
Sign-up for InVivo Therapeutics Appoints Christopher McNulty as Vice President, Business Development & Investor Relations investment picks
http://media.marketwire.com/attachments/201310/193404_iPass_logo_color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1128007&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Sells Unity Business Unit to Tolt Solutions for $28.2 Million investment picks
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for Somatuline ® Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In the European Union, Ipsen has submitted national marketing authorization variations for Somatuline ® Autogel ® 120mg injection to the drug regulatory authorities in 25 countries.
Sign-up for Ipsen submits marketing authorization applications in the U.S. and Europe for Somatuline® (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for Somatuline ® Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In the European Union, Ipsen has submitted national marketing authorization variations for Somatuline ® Autogel ® 120mg injection to the drug regulatory authorities in 25 countries of the European Union.
Sign-up for Ipsen submits marketing authorization applications in the US and Europe for Somatuline® (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Insignia Systems, Inc. Added to Russell Microcap® Index to Ipsen submits marketing authorization applications in the US and Europe for Somatuline® (lanreotide) in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices